Anti-MAVS 抗体 [EPR26357-91] (BSA and Azide free) (ab290744)
Key features and details
- Produced recombinantly (animal-free) for high batch-to-batch consistency and long term security of supply
- Rabbit monoclonal [EPR26357-91] to MAVS - BSA and Azide free
- Suitable for: WB, IHC-P, IP, Flow Cyt (Intra), ICC/IF
- Reacts with: Human
Related conjugates and formulations
製品の概要
-
製品名
Anti-MAVS antibody [EPR26357-91] (BSA and Azide free)
MAVS 一次抗体 製品一覧 -
製品の詳細
Rabbit monoclonal [EPR26357-91] to MAVS - BSA and Azide free -
由来種
Rabbit -
アプリケーション
適用あり: WB, IHC-P, IP, Flow Cyt (Intra), ICC/IFmore details
適用なし: IHC-Fr -
種交差性
交差種: Human
非交差種: Mouse, Rat -
免疫原
Recombinant fragment. This information is proprietary to Abcam and/or its suppliers.
-
ポジティブ・コントロール
- WB: HeLa (human cervix adenocarcinoma epithelial cell) and 293T (human embryonic kidney epithelial cell) whole cell fresh lysates. IHC-P: Human skeletal and cardiac muscle, human lung and ovarian carcinoma. ICC/IF: 293T (human embryonic kidney epithelial cell). Flow Cyt. (Intra): 293T (human embryonic kidney epithelial cell) IP: HeLa (human cervix adenocarcinoma epithelial cell) and 293T (human embryonic kidney epithelial cell) whole cell fresh lysates.
-
特記事項
Our carrier-free antibodies are typically supplied in a PBS-only formulation, purified and free of BSA, sodium azide and glycerol. The carrier-free buffer and high concentration allow for increased conjugation efficiency.
This conjugation-ready format is designed for use with fluorochromes, metal isotopes, oligonucleotides, and enzymes, which makes them ideal for antibody labelling, functional and cell-based assays, flow-based assays (e.g. mass cytometry) and Multiplex Imaging applications.
Use our conjugation kits for antibody conjugates that are ready-to-use in as little as 20 minutes with <1 minute hands-on-time and 100% antibody recovery: available for fluorescent dyes, HRP, biotin and gold.
This product is compatible with the Maxpar® Antibody Labeling Kit from Fluidigm, without the need for antibody preparation. Maxpar® is a trademark of Fluidigm Canada Inc.
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free production
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
製品の特性
-
製品の状態
Liquid -
保存方法
Shipped at 4°C. Store at +4°C. -
バッファー
pH: 7.20
Constituent: 100% PBS -
キャリア・フリー
はい -
Concentration information loading...
-
精製度
Protein A purified -
ポリ/モノ
モノクローナル -
クローン名
EPR26357-91 -
アイソタイプ
IgG -
研究分野
関連製品
-
Alternative Versions
-
Compatible Secondaries
-
Isotype control
-
Related Products
アプリケーション
The Abpromise guarantee
Abpromise保証は、 次のテスト済みアプリケーションにおけるab290744の使用に適用されます
アプリケーションノートには、推奨の開始希釈率がありますが、適切な希釈率につきましてはご検討ください。
アプリケーション | Abreviews | 特記事項 |
---|---|---|
WB |
Use at an assay dependent concentration. Predicted molecular weight: 57 kDa.
|
|
IHC-P |
Use at an assay dependent concentration. Perform heat mediated antigen retrieval with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol.
|
|
IP |
Use at an assay dependent concentration.
|
|
Flow Cyt (Intra) |
Use at an assay dependent concentration.
|
|
ICC/IF |
Use at an assay dependent concentration.
|
特記事項 |
---|
WB
Use at an assay dependent concentration. Predicted molecular weight: 57 kDa. |
IHC-P
Use at an assay dependent concentration. Perform heat mediated antigen retrieval with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol. |
IP
Use at an assay dependent concentration. |
Flow Cyt (Intra)
Use at an assay dependent concentration. |
ICC/IF
Use at an assay dependent concentration. |
ターゲット情報
-
機能
Required for innate immune defense against viruses. Acts downstream of DDX58 and IFIH1/MDA5, which detect intracellular dsRNA produced during viral replication, to coordinate pathways leading to the activation of NF-kappa-B, IRF3 and IRF7, and to the subsequent induction of antiviral cytokines such as IFN-beta and RANTES (CCL5). May activate the same pathways following detection of extracellular dsRNA by TLR3. May protect cells from apoptosis. -
組織特異性
Present in T-cells, monocytes, epithelial cells and hepatocytes (at protein level). Ubiquitously expressed, with highest levels in heart, skeletal muscle, liver, placenta and peripheral blood leukocytes. -
配列類似性
Contains 1 CARD domain. -
ドメイン
Both CARD and transmembrane domains are essential for antiviral function. The CARD domain is responsible for interaction with DDX58 and IFIH1. -
翻訳後修飾
Ubiquitinated; undergoes 'Lys-48'-linked polyubiquitination catalyzed by ITCH; ITCH-dependent polyubiquitination is mediated by the interaction with PCBP2 and leads to MAVS proteasomal degradation. -
細胞内局在
Mitochondrion outer membrane. - Information by UniProt
-
参照データベース
- Entrez Gene: 57506 Human
- Omim: 609676 Human
- SwissProt: Q7Z434 Human
- Unigene: 570362 Human
-
別名
- CARD adapter inducing interferon beta antibody
- CARD adaptor inducing IFN beta antibody
- Cardif antibody
see all
画像
-
All lanes : Anti-MAVS antibody [EPR26357-91] (ab290729) at 1/1000 dilution
Lane 1 : HeLa (human cervix adenocarcinoma epithelial cell) whole cell fresh lysate
Lane 2 : 293T (human embryonic kidney epithelial cell) whole cell fresh lysate
Lysates/proteins at 20 µg per lane.
Secondary
All lanes : Goat Anti-Rabbit IgG H&L (HRP) (ab97051) at 1/100000 dilution
Predicted band size: 57 kDa
Observed band size: 75 kDa why is the actual band size different from the predicted?
Additional bands at: 30 kDa (possible cleavage fragment), 37 kDa (possible cleavage fragment), 52 kDa (possible cleavage fragment)
Exposure time: 37 secondsThis data was developed using ab290729, the same antibody clone in a different buffer formulation.
Blocking / Diluting buffer and concentration:
5% NFDM/TBST
The molecular weight observed is consistent with that described in the literature (PMID: 16125763 and 30460894)
Lysates were prepared from fresh materials and used for Western blotting immediately to minimize protein degradation. -
This data was developed using ab290729, the same antibody clone in a different buffer formulation.
Immunohistochemical analysis of paraffin-embedded human skeletal muscle labeling MAVS with ab290729 at 1/500 dilution followed by a ready to use Leica DS9800 (BOND™ Polymer Refine Detection). Positive cytoplasmic staining on Human skeletal muscle. The section was incubated with ab290729 for 30 mins at room temperature. The immunostaining was performed on a Leica Biosystems BOND® RX instrument. Counterstained with Hematoxylin.
Secondary antibody only control: PBS was used instead of primary antibody followed by ready to use secondary antibody LeicaDS9800 (BOND™ Polymer Refine Detection).
Heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0, epitope retrieval solution2) for 20 mins.
-
This data was developed using ab290729, the same antibody clone in a different buffer formulation.
Immunohistochemical analysis of paraffin-embedded human cardiac muscle labeling MAVS with ab290729 at 1/500 dilution followed by a ready to use Leica DS9800 (BOND™ Polymer Refine Detection). Positive cytoplasmic staining on human cardiac muscle is observed. The section was incubated with ab290729 for 30 mins at room temperature. The immunostaining was performed on a Leica Biosystems BOND® RX instrument. Counterstained with Hematoxylin.
Secondary antibody only control: PBS was used instead of primary antibody followed by ready to use secondary antibody LeicaDS9800 (BOND™ Polymer Refine Detection).
Heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0, epitope retrieval solution2) for 20 mins.
-
This data was developed using ab290729, the same antibody clone in a different buffer formulation.
Immunohistochemical analysis of paraffin-embedded human lung carcinoma labeling MAVS with ab290729 at 1/500 dilution followed by a ready to use Leica DS9800 (BOND™ Polymer Refine Detection). Positive cytoplasmic staining on human lung carcinoma is observed. The section was incubated with ab290729 for 30 mins at room temperature. The immunostaining was performed on a Leica Biosystems BOND® RX instrument. Counterstained with Hematoxylin.
Secondary antibody only control: PBS was used instead of primary antibody followed by ready to use secondary antibody LeicaDS9800 (BOND™ Polymer Refine Detection).
Heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0, epitope retrieval solution2) for 20 mins.
-
This data was developed using ab290729, the same antibody clone in a different buffer formulation.
Immunohistochemical analysis of paraffin-embedded human ovarian carcinoma labeling MAVS with ab290729 at 1/500 dilution followed by a ready to use Leica DS9800 (BOND™ Polymer Refine Detection). Positive cytoplasmic staining on human ovarian carcinoma is observed. The section was incubated with ab290729 for 30 mins at room temperature. The immunostaining was performed on a Leica Biosystems BOND® RX instrument. Counterstained with Hematoxylin.
Secondary antibody only control: PBS was used instead of primary antibody followed by a ready to use secondary antibody LeicaDS9800 (BOND™ Polymer Refine Detection).
Heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0, epitope retrieval solution2) for 20 mins.
-
This data was developed using ab290729, the same antibody clone in a different buffer formulation.
Immunofluorescent analysis of 4% paraformaldehyde 293T (human embryonic kidney epithelial) cells labeling MAVS with ab290729 at 1:50 dilution, followed by ab150081 Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) preadsorbed secondary antibody at 1/1000 dilution (Green). Confocal image showing mitochondrial staining on 293T cell line. ab33985 Anti-COX IV mouse monoclonal antibody - Mitochondrial Marker (1/1000 dilution) and ab150120 Goat Anti-Mouse IgG H&L (Alexa Fluor® 594) (1/1000) was used to label mitochondria (RED) as a counterstain. DAPI was used as a nuclear counterstain (BLUE).
The negative controls are as follows:
-ve control 1: Primary (ab290729) at 1/50 dilution, followed by secondary Goat Anti-Mouse IgG H&L (Alexa Fluor® 594) (ab150120) at 1/1000 dilution.
-ve control 2: Primary (ab33985) at 1/1000 dilution, followed by Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) preadsorbed (ab150081) secondary at 1/1000 dilution. -
This data was developed using ab290729, the same antibody clone in a different buffer formulation.
Intracellular Flow Cytometry analysis of 293T (human embryonic kidney epithelial) cells labeling MAVS (red) with ab290729 at a 1/500 dilution. Cells were fixed with 4% paraformaldehyde and permeabilized with 90% methanol. A Goat Anti-Rabbit IgG (Alexa Fluor® 488, ab150081) was used as the secondary antibody at a 1/2000 dilution. Black - isotype control: Rabbit monoclonal IgG (ab172730). Blue - unlabeled control: Cells without incubation with primary and secondary antibodies.
-
This data was developed using ab290729, the same antibody clone in a different buffer formulation.
MAVS was immunoprecipitated from 10 μg HeLa (human cervix adenocarcinoma epithelial cell) whole cell fresh lysate with ab290729 at 1/30 dilution. Western blot was performed from the immunoprecipitate using ab290729 at 1/1000 dilution. VeriBlot for IP secondary antibody (HRP) (ab131366), was used as secondary antibody at 1/5000 dilution.
Lane 1: HeLa (human cervix adenocarcinoma epithelial cell) whole cell fresh lysate 10 μg (Input).
Lane 2: ab290729 IP in HeLa whole cell fresh lysate.
Lane 3: Rabbit monoclonal IgG (ab172730) instead of ab290744 in HeLa whole cell fresh lysate.
Blocking and dilution buffer and concentration: 5% NFDM/TBST.
Exposure time: 10 seconds.Lysates were made fresh and used immediately to minimize protein degradation. The bands beneath the target band (75 kDa) are expected to be degradation products.
-
This data was developed using ab290729, the same antibody clone in a different buffer formulation.
MAVS was immunoprecipitated from 10 μg 293T (human embryonic kidney epithelial cell) whole cell fresh lysate with ab290729 at 1/30 dilution. Western blot was performed from the immunoprecipitate using ab290729 at 1/1000 dilution. VeriBlot for IP secondary antibody (HRP) (ab131366), was used as secondary antibody at 1/5000 dilution.
Lane 1: 293T (human embryonic kidney epithelial cell) whole cell fresh lysate 10 μg (Input).
Lane 2: ab290729 IP in 293T whole cell lysate.
Lane 3: Rabbit monoclonal IgG (ab172730) instead of ab290744 in HeLa whole cell fresh lysate.
Blocking and dilution buffer and concentration: 5% NFDM/TBST.
Exposure time: 10 seconds.The bands beneath the target band could be degradation or cleavage product, as demonstrated by the use of fresh lysate in the WB data.
プロトコール
To our knowledge, customised protocols are not required for this product. Please try the standard protocols listed below and let us know how you get on.
データシートおよび資料
-
Datasheet download
Certificate of Compliance
参考文献 (0)
ab290744 は論文での使用が確認できていません。